Case Reports Identify Guillain-Barr é Variants After COVID Vaccine Case Reports Identify Guillain-Barr é Variants After COVID Vaccine
Report findings from India and the UK ' should prompt all physicians to be vigilant in recognizing Guillain-Barr é syndrome in patients who have received the AstraZeneca vaccine, ' investigators say.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news
More News: AstraZeneca | Brain | Guillain-Barr Syndrome | India Health | Infectious Diseases | Neurology | Neurosurgery | Vaccines